Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-002485

President and CEO sold 50,000 shares at an average $46.19 ($2,309,454)

  • President and CEO acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Torley Helen · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-01 Exercise or conversion : show line 1 in the form +50,000 $14.66 $733,000 587,160 D
2021-03-01 Sale : show line 2 in the form −16,110 $45.58 $734,342 571,050 D
2021-03-01 Sale : show line 3 in the form −33,890 $46.48 $1,575,112 537,160 D
Open-market sales · 50,000 sh · avg $46.19 · $2,309,454

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2021-03-01 Exercise or conversion : show line 4 in the form Option to Purchase Common Stock −50,000 $14.66 $733,000 $14.66 2024-01-06 50,000 550,000 D
Loading xslF345X03/edgar.xml…